Articles related to CARDIAC SURGERY

In this multicenter trial of 901 patients with asymptomatic severe aortic stenosis, early TAVR intervention reduced the composite endpoint of death, stroke, or unplanned cardiovascular hospitalization by 50% compared to clinical surveillance.

The bRIGHT study demonstrates that T-TEER using the TriClip system can lead to sustained TR reduction and quality of life improvements in a diverse, real-world population with advanced tricuspid valve disease.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Pulmonary thromboendarterectomy (PTE) offers significant symptom improvement for over 75% of CTEPH patients. Specialized care centers are critical for successful outcomes due to the complexity of the procedure.

A recent randomized trial demonstrated that intravenous amino acid infusions can significantly reduce the incidence of acute kidney injury in patients undergoing cardiac surgery, highlighting a potential new approach to mitigating this common complication.

In a recent study among low-risk aortic stenosis patients, transcatheter aortic-valve implantation (TAVI) demonstrated a significant reduction in the combined endpoint of death or stroke at one year compared to surgical replacement, suggesting its potential as a safer alternative in selected patient groups.